These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16998918)

  • 1. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.
    Horita Y; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Neurosci Res; 2006 Nov; 84(7):1495-504. PubMed ID: 16998918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Nomura T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    Neuroscience; 2005; 136(1):161-9. PubMed ID: 16229956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
    Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
    Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.
    Onda T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):329-40. PubMed ID: 17637706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats.
    Cheng H; Huang SS; Lin SM; Lin MJ; Chu YC; Chih CL; Tsai MJ; Lin HC; Huang WC; Tsai SK
    Brain Res; 2005 Feb; 1033(1):28-33. PubMed ID: 15680336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.
    Komatsu K; Honmou O; Suzuki J; Houkin K; Hamada H; Kocsis JD
    Brain Res; 2010 Jun; 1334():84-92. PubMed ID: 20382136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.
    Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
    Mol Ther; 2004 Feb; 9(2):189-97. PubMed ID: 14759803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effects of Brain-Derived Neurotrophic Factor and Noggin-Modified Bone Mesenchymal Stem Cells in Focal Cerebral Ischemia in Rats.
    Lu H; Liu X; Zhang N; Zhu X; Liang H; Sun L; Cheng Y
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):410-8. PubMed ID: 26654668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
    Omori Y; Honmou O; Harada K; Suzuki J; Houkin K; Kocsis JD
    Brain Res; 2008 Oct; 1236():30-8. PubMed ID: 18722359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regeneration.
    Gheisari Y; Yokoo T; Matsumoto K; Fukui A; Sugimoto N; Ohashi T; Kawamura T; Hosoya T; Kobayashi E
    Artif Organs; 2010 Aug; 34(8):642-7. PubMed ID: 20497162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
    Honma T; Honmou O; Iihoshi S; Harada K; Houkin K; Hamada H; Kocsis JD
    Exp Neurol; 2006 May; 199(1):56-66. PubMed ID: 15967439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.
    Iihoshi S; Honmou O; Houkin K; Hashi K; Kocsis JD
    Brain Res; 2004 May; 1007(1-2):1-9. PubMed ID: 15064130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recapitulation of in vivo-like paracrine signals of human mesenchymal stem cells for functional neuronal differentiation of human neural stem cells in a 3D microfluidic system.
    Yang K; Park HJ; Han S; Lee J; Ko E; Kim J; Lee JS; Yu JH; Song KY; Cheong E; Cho SR; Chung S; Cho SW
    Biomaterials; 2015 Sep; 63():177-88. PubMed ID: 26113074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats.
    Liu Y; Wang S; Luo S; Li Z; Liang F; Zhu Y; Pei Z; Huang R
    Neurosci Lett; 2016 Mar; 617():150-5. PubMed ID: 26876444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) expression protects against subsequent cortical cold injury in rats.
    Hermann DM; Kilic E; Kügler S; Isenmann S; Bähr M
    Neurobiol Dis; 2001 Dec; 8(6):964-73. PubMed ID: 11741392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia.
    Zheng W; Honmou O; Miyata K; Harada K; Suzuki J; Liu H; Houkin K; Hamada H; Kocsis JD
    Brain Res; 2010 Jan; 1310():8-16. PubMed ID: 19913518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.
    Suzuki J; Sasaki M; Harada K; Bando M; Kataoka Y; Onodera R; Mikami T; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
    Brain Res; 2013 Feb; 1497():15-22. PubMed ID: 23274536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.